BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21139214)

  • 21. Grb7-based molecular therapeutics in cancer.
    Pero SC; Daly RJ; Krag DN
    Expert Rev Mol Med; 2003 May; 5(14):1-11. PubMed ID: 14585167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Water-refined solution structure of the human Grb7-SH2 domain in complex with the erbB2 receptor peptide pY1139.
    Pias SC; Johnson DL; Smith DE; Lyons BA
    Protein Pept Lett; 2012 Aug; 19(8):832-8. PubMed ID: 22702899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.
    Stein EG; Ghirlando R; Hubbard SR
    J Biol Chem; 2003 Apr; 278(15):13257-64. PubMed ID: 12551896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The discovery of phenylbenzamide derivatives as Grb7-based antitumor agents.
    Ambaye ND; Gunzburg MJ; Lim RC; Price JT; Wilce MC; Wilce JA
    ChemMedChem; 2013 Feb; 8(2):280-8. PubMed ID: 23355456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grb7 binds to Hax-1 and undergoes an intramolecular domain association that offers a model for Grb7 regulation.
    Siamakpour-Reihani S; Peterson TA; Bradford AM; Argiros HJ; Haas LL; Lor SN; Haulsee ZM; Spuches AM; Johnson DL; Rohrschneider LR; Shuster CB; Lyons BA
    J Mol Recognit; 2011; 24(2):314-21. PubMed ID: 20665473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Backbone nuclear relaxation characteristics and calorimetric investigation of the human Grb7-SH2/erbB2 peptide complex.
    Ivancic M; Spuches AM; Guth EC; Daugherty MA; Wilcox DE; Lyons BA
    Protein Sci; 2005 Jun; 14(6):1556-69. PubMed ID: 15930003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary crystallographic characterization of the Grb2 SH2 domain in complex with a FAK-derived phosphotyrosyl peptide.
    Chen HH; Chen CW; Chang YY; Shen TL; Hsu CH
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Feb; 66(Pt 2):195-7. PubMed ID: 20124721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimerization in the Grb7 protein.
    Peterson TA; Benallie RL; Bradford AM; Pias SC; Yazzie J; Lor SN; Haulsee ZM; Park CK; Johnson DL; Rohrschneider LR; Spuches A; Lyons BA
    J Mol Recognit; 2012 Aug; 25(8):427-34. PubMed ID: 22811067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adapter protein Grb7.
    Pandey A; Liu X; Dixon JE; Di Fiore PP; Dixit VM
    J Biol Chem; 1996 May; 271(18):10607-10. PubMed ID: 8631863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.
    Yokote K; Margolis B; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1996 Nov; 271(48):30942-9. PubMed ID: 8940081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain.
    Scharf PJ; Witney J; Daly R; Lyons BA
    Protein Sci; 2004 Sep; 13(9):2541-6. PubMed ID: 15322292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of focal adhesion kinase with Grb7 and its role in cell migration.
    Han DC; Guan JL
    J Biol Chem; 1999 Aug; 274(34):24425-30. PubMed ID: 10446223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grb7 protein RA domain oligomerization.
    Godamudunage MP; Foster A; Warren D; Lyons BA
    J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28295715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct Interaction between Calmodulin and the Grb7 RA-PH Domain.
    Watson GM; Wilce JA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7.
    Janes PW; Lackmann M; Church WB; Sanderson GM; Sutherland RL; Daly RJ
    J Biol Chem; 1997 Mar; 272(13):8490-7. PubMed ID: 9079677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification, crystallization and preliminary X-ray diffraction analysis of human enolase-phosphatase E1.
    Wang H; Pang H; Ding Y; Li Y; Wu X; Rao Z
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 May; 61(Pt 5):521-3. PubMed ID: 16511085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide.
    Watson GM; Kulkarni K; Brandt R; Del Borgo MP; Aguilar MI; Wilce JA
    ACS Omega; 2017 Feb; 2(2):670-677. PubMed ID: 29152602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystallization and preliminary crystallographic analysis of the NAD(H)-binding domain of Escherichia coli transhydrogenase.
    Oswald C; Johansson T; Törnroth S; Okvist M; Krengel U
    Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):743-5. PubMed ID: 15039572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.
    Ivancic M; Daly RJ; Lyons BA
    J Biomol NMR; 2003 Nov; 27(3):205-19. PubMed ID: 12975581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists.
    Ambaye ND; Gunzburg MJ; Lim RC; Price JT; Wilce MC; Wilce JA
    Bioorg Med Chem; 2011 Jan; 19(1):693-701. PubMed ID: 21134757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.